Leadership – inCytes 3.0

Select Use Cases

LEADERSHIP

Clinical / Scientific Advisory Board

Diego Correa, M.D., Ph.D.

The Diego Correa Laboratory
University of Miami Health System

Dr. Correa holds various patent submissions; is author and co-author of a significant number of scientific publications in recognized journals; serves on the editorial board and as peer reviewer of various recognized scientific journals; serves as formal reviewer for scientific institutions both nationally (e.g.: California Institute of Regenerative Medicine – CIRM) and internationally (National Medical Research Council of Singapore); and is a frequent invited speaker and lecturer in national and international scientific and medical meetings.

Dan A. Grande, Ph.D.

Feinstein Institutes For Medical Research
Northwell Health

Dr. Grande is widely recognized as a world leader in cartilage repair. He pioneered the first cell-based therapy for articular cartilage repair. These studies led to the commercialization of cartilage transplantation for the current surgical treatment of focal cartilage defects in clinical use today—autologous chondrocyte transplantation.

Lisa A. Fortier, Ph.D., D.V.M.

Fortier Laboratory
Cornell University

Dr. Fortier is the Vice President of the International Veterinary Regenerative Medicine Society and a Past President of the International Cartilage Repair Society. She has published over 100 manuscripts in subjects related to sports medicine and is a recognized world leader of regenerative medicine for both the human and equine athletes.

J. William Futrell, M.D.

Former Chair, Dept. of Plastic/Reconstructive Surgery
University of Pittsburgh Medical Center

Former Professor and Chief of Plastic Surgery at the University of Pittsburgh Medical Center for 21 years. Dr. Futrell served as a President of the American Association of Plastic Surgeons and multiple other medical organizations and author or co-author of more than 200 peer-reviewed scientific publications.

Peter Johnson, M.D.

Co-Founder, Pittsburgh Tissue Engineering Initiative
University of Pittsburgh Medical Center

Dr. Johnson practiced reconstructive surgery for ten years at U. Pittsburgh where he founded and was the first President of the Pittsburgh Tissue Engineering Initiative. Subsequent roles were co-founder/CEO of Tissue Informatics, EVP of Life Sciences, CMO and CBO of Icoria, EVP, Entegrion, Inc. and VP, Research and Development and Medical and Scientific Affairs of Vancive Medical Technologies, an Avery Dennison business. He presently serves as President and CEO of Scintellix, LLC and Chief Medical Advisor to Vancive Medical Technologies.

Christian Jorgensen, M.D., M.B.A.

Director, Institute for Regenerative Medicine and Biotherapy University of Montpellier

Christian Jorgensen leads Institute IRMB dedicated to regenerative medicine, and the clinical department for immunotherapy with 20 beds dedicated to biotherapy applied to Rheumatoid Arthritis and other autoimmune diseases. Pr Christian Jorgensen, specialist in Therapeutics and Rheumatology, is head of research INSERM unit U844 (“mesenchymal stem cells, joint environment and immunotherapy of Rheumatoid arthritis”) Hôpital Saint Eloi – INM (Montpellier – France).

John G. Kennedy, M.D.

Department of Orthopedic Surgery
NYU Langone Health

As one of the founding members of the International Society on Cartilage Repair of the Ankle (ISCRA), Dr. Kennedy helped pioneer innovative technologies to help prevent cartilage degeneration.

Claude “T.” Moorman, III, M.D.

President, Musculoskeletal Institute Atrium Health

Dr. Moorman is a leader in advancing treatments for shoulder and knee reconstructions with a special interest in multiple ligament knee injury and regenerative medicine. He has authored more than 150 publications and his research has been recognized with numerous honors, including the Neer Award and the Excellence in Research Award for innovations in shoulder reconstruction.

J. Peter Rubin, M.D., M.B.A.

Chair, Dept. of Plastic/Reconstructive Surgery
University of Pittsburgh Medical Center

Dr. Rubin is a noted expert on adult stem cells derived from fat tissue and advanced reconstructive surgery. Dr. Rubin leads a program that is devising innovative strategies for the use of adipose (fat)-derived stem cells to not only address problems of tissue regeneration but also other diseases that benefit from stem cell-based therapies. He is co-director of the Adipose Stem Cell Center and co-director of the UPMC Aesthetic Plastic Surgery Center. His laboratory research focuses on applications of adult adipose-derived stem cells for restoring damaged tissues after trauma and cancer therapy.

Alan Russell, Ph.D.

Director, Disruptive Health Technology Institute Carnegie Mellon University

Dr. Russell serves on the Science Board to the Food and Drug Administration and recently Chaired the scientific review sub-committee for the Center for Devices and Radiologic Health. Dr. Russell has served many scientific roles for the Department of Defense, including being a member of the Defense Health Board and the founding Co-Director of the Armed Forces Institute for Regenerative Medicine.

James R. Urbaniak, M.D.

James R. Urbaniak Sports Science Institute
Duke Health

James R. Urbaniak, MD is recognized as a pioneer in the replantation of severed digits and hands. For the past 40 years he has conducted significant research in the area of microsurgical reconstruction of traumatized extremities and avascular necrosis of the femoral head. This research has been supported for over 20 years by a R01 grant from the National Institutes of Health.